Security key
23284F105
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (CTMX)
CUSIP: 23284F105
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, $0.00001 par value per share ("Common Stock")
- Shares outstanding
- 217,079,600
- Total 13F shares
- 46,714,805
- Share change
- -4,930,602
- Total reported value
- $48,111,898
- Put/Call ratio
- 127%
- Price per share
- $1.03
- Number of holders
- 68
- Value change
- -$6,381,441
- Number of buys
- 31
- Number of sells
- 31
Report period
Q4 2024
Institutions
68
Top holders
10
CTMX full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
CytomX Therapeutics, Inc. SEC filings
CytomX Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 23284F105
Recent filing periods:
Top shareholders of CTMX - CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.6%
|
7,811,760
|
$9,217,877 | — | 30 Sep 2024 | |
| BVF INC/IL |
13F
|
Company |
2.4%
|
5,228,461
|
$6,169,584 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.4%
|
5,162,302
|
$6,091,517 | — | 30 Sep 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.2%
|
4,809,518
|
$5,699,279 | — | 30 Sep 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.4%
|
3,100,994
|
$3,655,000 | — | 30 Sep 2024 | |
| Prosight Management, LP |
13F
|
Company |
1.4%
|
3,022,109
|
$3,566,089 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.4%
|
3,000,000
|
$3,540,000 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.2%
|
2,560,256
|
$3,021,102 | — | 30 Sep 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.76%
|
1,644,168
|
$1,940,118 | — | 30 Sep 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.7%
|
1,524,076
|
$1,798,410 | — | 30 Sep 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
0.58%
|
1,248,364
|
$1,473,070 | — | 30 Sep 2024 | |
| Congress Park Capital LLC |
13F
|
Company |
0.56%
|
1,216,008
|
$1,434,890 | — | 30 Sep 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.56%
|
1,211,800
|
$1,429,924 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.54%
|
1,168,566
|
$1,378,908 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.47%
|
1,015,000
|
$1,197,700 | — | 30 Sep 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.42%
|
915,000
|
$1,079,700 | — | 30 Sep 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.42%
|
903,959
|
$1,066,672 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
803,531
|
$948,369 | — | 30 Sep 2024 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.22%
|
487,902
|
$575,724 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.22%
|
471,468
|
$556,332 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.18%
|
393,832
|
$464,722 | — | 30 Sep 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
356,624
|
$420,816 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.15%
|
317,119
|
$374,200 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
0.13%
|
284,307
|
$335,482 | — | 30 Sep 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.13%
|
280,593
|
$331,100 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.12%
|
263,643
|
$311,099 | — | 30 Sep 2024 | |
| Formidable Asset Management, LLC |
13F
|
Company |
0.11%
|
246,001
|
$290,281 | — | 30 Sep 2024 | |
| Tidal Investments LLC |
13F
|
Company |
0.11%
|
246,001
|
$290,281 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
241,982
|
$285,539 | — | 30 Sep 2024 | |
| Jeffrey B. Landau |
3/4/5
|
Chief Business Officer |
—
mixed-class rows
|
266,736
mixed-class rows
|
$155,772 | — | 20 Aug 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
129,886
|
$153,265 | — | 30 Sep 2024 | |
| Creative Planning |
13F
|
Company |
0.05%
|
107,000
|
$126,260 | — | 30 Sep 2024 | |
| Virtu Financial LLC |
13F
|
Company |
0.04%
|
88,518
|
$104,000 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
69,135
|
$81,579 | — | 30 Sep 2024 | |
| Amy C. Peterson |
3/4/5
|
EVP, Chief Development Officer |
—
class O/S missing
|
58,433
|
$80,678 | — | 16 Mar 2023 | |
| Forefront Analytics, LLC |
13F
|
Company |
0.03%
|
59,760
|
$70,518 | — | 30 Sep 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.03%
|
55,108
|
$65,027 | — | 30 Sep 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.02%
|
54,243
|
$64,000 | — | 30 Sep 2024 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.02%
|
52,179
|
$61,571 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
50,368
|
$59,434 | — | 30 Sep 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.02%
|
47,649
|
$56,224 | — | 30 Sep 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.02%
|
46,100
|
$54,398 | — | 30 Sep 2024 | |
| Carlos Campoy |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
38,224
|
$52,776 | — | 16 Mar 2023 | |
| XTX Topco Ltd |
13F
|
Company |
0.02%
|
43,664
|
$51,524 | — | 30 Sep 2024 | |
| CORNERCAP INVESTMENT COUNSEL INC |
13F
|
Company |
0.02%
|
41,458
|
$48,920 | — | 30 Sep 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.02%
|
38,315
|
$45,212 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.02%
|
37,464
|
$44,208 | — | 30 Sep 2024 | |
| Alison L. Hannah |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
31,898
|
$44,042 | — | 19 Jul 2022 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.02%
|
36,500
|
$43,070 | — | 30 Sep 2024 | |
| US BANCORP \DE\ |
13F
|
Company |
0.02%
|
33,792
|
$39,875 | — | 30 Sep 2024 |
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (CTMX) as of Q4 2024
As of 31 Dec 2024,
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (CTMX) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,714,805 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, BVF INC/IL, VANGUARD GROUP INC, Prosight Management, LP, MILLENNIUM MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, Point72 Asset Management, L.P., JACOBS LEVY EQUITY MANAGEMENT, INC, Schonfeld Strategic Advisors LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
69
Q4 2024 holders
68
Holder diff
-1
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.